Cited by 50

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver

Wu, Y, Wang, Y Y, Nakamoto, Y, Li, Y-Y, Baba, T, Kaneko, S, Fujii, C, Mukaida, N·2010·Oncogene

DOI 10.1038/onc.2009.504

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/onc.2009.504

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL
Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,614
Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death
Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson, C. B., & Korsmeyer, S. J. (1995) · Cell · doi:10.1016/0092-8674(95)90411-5 · Cited by 2,100
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1934 · Cited by 2,027
Differential Targeting of Prosurvival Bcl-2 Proteins by Their BH3-Only Ligands Allows Complementary Apoptotic Function
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816
Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis
Maeda, S., Kamata, H., Luo, J., Leffert, H. L., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,178
Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor
Yamada, Y., Kirillova, I., Peschon, J. J., & Fausto, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1441 · Cited by 944
Involvement of Interleukin-8, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Tumor Necrosis Factor Alpha-Dependent Angiogenesis
Yoshida, S., Ono, M., Shono, T., Izumi, H., Ishibashi, T., Suzuki, H., & Kuwano, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4015 · Cited by 696
Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways
Schwabe, R. F., & Brenner, D. A. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00422.2005 · Cited by 685
N-Nitrosodiethylamine mechanistic data and risk assessment: Bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation
Verna, L. (1996) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(96)00062-9 · Cited by 514
The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells
She, Q., Solit, D. B., Ye, Q., O'Reilly, K. E., Lobo, J. M., & Rosen, N. X. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.006 · Cited by 425
Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation
Sakurai, T., Maeda, S., Chang, L., & Karin, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603499103 · Cited by 400
Mecanismos de lesión hepatocelular
Muntané, J., González, R., Ranchal, I., Collado, J. A., López-Sánchez, L. M., Herencia, C., Rodríguez-Ariza, A., Muñoz-Castañeda, J. R., & de la Mata, M. (2007) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082007000700007 · Cited by 349
An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice.
Pinkert, C. A., Ornitz, D. M., Brinster, R. L., & Palmiter, R. D. (1987) · Genes & Development · doi:10.1101/gad.1.3.268 · Cited by 315
Pim Kinases Promote Cell Cycle Progression by Phosphorylating and Down-regulating p27Kip1 at the Transcriptional and Posttranscriptional Levels
Morishita, D., Katayama, R., Sekimizu, K., Tsuruo, T., & Fujita, N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0634 · Cited by 309
Structural Basis of Constitutive Activity and a Unique Nucleotide Binding Mode of Human Pim-1 Kinase
Qian, K. C., Wang, L., Hickey, E. R., Studts, J., Barringer, K., Peng, C., Kronkaitis, A., Li, J., White, A., Mische, S. M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409123200 · Cited by 306
Physical and Functional Interactions between Pim-1 Kinase and Cdc25A Phosphatase
Mochizuki, T., Kitanaka, C., Noguchi, K., Muramatsu, T., Asai, A., & Kuchino, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18659 · Cited by 246
Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture.
Tamura, M., Arakaki, N., Tsubouchi, H., Takada, H., & Daikuhara, Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53072-6 · Cited by 222
Structure and Substrate Specificity of the Pim-1 Kinase
Bullock, A. N., Debreczeni, J. E., Amos, A. L., Knapp, S., & Turk, B. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510711200 · Cited by 206
Epidemiology of hepatocellular carcinoma in Japan
Umemura, T., Ichijo, T., Yoshizawa, K., et al. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-008-2251-0 · Cited by 201
Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase
Wang, Z., Bhattacharya, N., Mixter, P. F., Wei, W., Sedivy, J. M., & Magnuson, N. S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00347-6 · Cited by 197
Leflunomide Suppresses TNF-Induced Cellular Responses: Effects on NF-κB, Activator Protein-1, c-Jun N-Terminal Protein Kinase, and Apoptosis
Manna, S. K., Mukhopadhyay, A., & Aggarwal, B. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5962 · Cited by 185
CCL3-CCR5 Axis Regulates Intratumoral Accumulation of Leukocytes and Fibroblasts and Promotes Angiogenesis in Murine Lung Metastasis Process
Wu, Y., Li, Y.-Y., Matsushima, K., Baba, T., & Mukaida, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6384 · Cited by 171
Self-citation
Pim-3, a Proto-Oncogene with Serine/Threonine Kinase Activity, Is Aberrantly Expressed in Human Pancreatic Cancer and Phosphorylates Bad to Block Bad-Mediated Apoptosis in Human Pancreatic Cancer Cell Lines
Li, Y.-Y., Popivanova, B. K., Nagai, Y., Ishikura, H., Fujii, C., & Mukaida, N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4272 · Cited by 163
Self-citation
The Oncogenic Serine/Threonine Kinase Pim-1 Phosphorylates and Inhibits the Activity of Cdc25C-associated Kinase 1 (C-TAK1)
Bachmann, M., Hennemann, H., Xing, P., Hoffmann, I., & Möröy, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404440200 · Cited by 147
O6-methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis.
Nakatsuru, Y., Matsukuma, S., Nemoto, N., Sugano, H., Sekiguchi, M., & Ishikawa, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6468 · Cited by 138
Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells
Otani, K., Korenaga, M., Beard, M. R., Li, K., Qian, T., Showalter, L., Singh, A. K., Wang, T., & Weinman, S. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.10.045 · Cited by 134
The PIM1 Kinase Is a Critical Component of a Survival Pathway Activated by Docetaxel and Promotes Survival of Docetaxel-treated Prostate Cancer Cells
Zemskova, M., Sahakian, E., Bashkirova, S., & Lilly, M. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709479200 · Cited by 129
Proto‐oncogene, Pim‐3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad‐mediated apoptosis
Popivanova, B. K., Li, Y., Zheng, H., Omura, K., Fujii, C., Tsuneyama, K., & Mukaida, N. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00390.x · Cited by 116
Self-citation
Quantitative analysis of estrogen receptor heterogeneity in breast cancer
Chung, G. G., Zerkowski, M. P., Ghosh, S., Camp, R. L., & Rimm, D. L. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700543 · Cited by 115
Production of hepatocellular carcinoma by oval cells: cell cycle expression of c-myc and p53 at different stages of oval cell transformation.
Braun, L., Mikumo, R., & Fausto, N. (1989) · PubMed · Cited by 102
Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression
Yang, X., Lu, P., Fujii, C., Nakamoto, Y., Gao, J., Kaneko, S., Murphy, P. M., & Mukaida, N. (2005) · International Journal of Cancer · doi:10.1002/ijc.21596 · Cited by 99
Self-citation
KID-1, a Protein Kinase Induced by Depolarization in Brain
Feldman, J. D., Vician, L. J., Crispino, M., Tocco, G., Marcheselli, V. L., Bazan, N. G., Baudry, M., & Herschman, H. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16535 · Cited by 98
Aberrant expression of serine/threonine kinase Pim‐3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines
Fujii, C., Nakamoto, Y., Lu, P., Tsuneyama, K., Popivanova, B. K., Kaneko, S., & Mukaida, N. (2004) · International Journal of Cancer · doi:10.1002/ijc.20719 · Cited by 93
Self-citation
Hepatitis B virus promotes hepatocarcinogenesis in transgenic mice
Zheng, Y.-Y., Chen, W.-L., Louie, S., Yen, T. S. B., & Ou, J. (2007) · Hepatology · doi:10.1002/hep.21445 · Cited by 85
Lymphocyte Transformation by Pim-2 Is Dependent on Nuclear Factor-κB Activation
Hammerman, P., Fox, C., Cinalli, R. M., Xu, A., Wagner, J., Lindsten, T., & Thompson, C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2284 · Cited by 81
Nonalcoholic steatohepatitis induced by a high‐fat diet promotes diethylnitrosamine‐initiated early hepatocarcinogenesis in rats
Wang, Y., Ausman, L. M., Greenberg, A. S., Russell, R. M., & Wang, X. (2008) · International Journal of Cancer · doi:10.1002/ijc.23995 · Cited by 80
Self-citation
PIM3 Proto-Oncogene Kinase Is a Common Transcriptional Target of Divergent EWS/ETS Oncoproteins
Deneen, B., Welford, S. M., Ho, T., Hernandez, F., Kurland, I. J., & Denny, C. T. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.11.3897-3908.2003 · Cited by 77
Aberrant Pim-3 expression is involved in gastric adenoma–adenocarcinoma sequence and cancer progression
Zheng, H., Tsuneyama, K., Takahashi, H., et al. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0310-1 · Cited by 70
Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
Hosono, S., Chou, M. J., Lee, C., et al. (1993) · PubMed · Cited by 68
Cytokines in non-genotoxic hepatocarcinogenesis
Roberts, R. A., & Kimber, I. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1397 · Cited by 59
1,25(OH)2D3 blocks TNF-induced monocytic tissue factor expression by inhibition of transcription factors AP-1 and NF-κB
Chung, J., Koyama, T., Ohsawa, M., Shibamiya, A., Hoshi, A., & Hirosawa, S. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700550 · Cited by 27
Expression of GCIP in transgenic mice decreases susceptibility to chemical hepatocarcinogenesis
Ma, W., Xia, X., Stafford, L. J., Yu, C., Wang, F., LeSage, G., & Liu, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209450 · Cited by 25
Interaction of AP-1 with a Cluster of NF-κB Binding Elements in the Human TNF Promoter Region
Udalova, I. A., & Kwiatkowski, D. P. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5929 · Cited by 22

The Critical Role of mRNA Destabilizing Protein Heterogeneous Nuclear Ribonucleoprotein D in 3′ Untranslated Region–Mediated Decay of Low-Density Lipoprotein Receptor mRNA in Liver Tissue
Singh, A. B., Li, H., Kan, C. F. K., Dong, B., Nicolls, M. R., & Liu, J. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.301131 · Cited by 32

See all 50

Authors: Wu, Y., Wang, Y. Y., Nakamoto, Y., Li, Y.-Y., Baba, T., Kaneko, S., Fujii, C., & Mukaida, N.
Venue: Oncogene
Publisher: Springer Science and Business Media LLC
Published: 2010-01-18
Volume: 29
Issue: 15
Pages: 2228-2237
ISSN: 0950-9232
1476-5594
DOI: 10.1038/onc.2009.504
Cited by: 50
References: 45
Language: en
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources